©The Author(s) 2025.
World J Hepatol. Dec 27, 2025; 17(12): 113639
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.113639
Published online Dec 27, 2025. doi: 10.4254/wjh.v17.i12.113639
Table 3 Baseline laboratory parameters in the steatotic liver disease and non-steatotic liver disease groups, median (Q1-Q3)
| Parameter | SLD (n = 290) | Non-SLD (n = 398) | P value |
| ALT (IU/L) | 71.0 (47-106) | 46 (32-76) | < 0.0001 |
| AST (IU/L) | 58.5 (40-95) | 38 (28-58) | < 0.0001 |
| GGTP (IU/L) | 67 (37-136) | 36.5 (20-71) | < 0.0001 |
| Albumin (g/dL) | 4.0 (3.6-4.4) | 4.1 (3.9-4.4) | 0.0028 |
| Bilirubin (mg/dL) | 0.7 (0.6-1.1) | 0.6 (0.5-0.9) | < 0.0001 |
| Haemoglobin (g/dL) | 14.6 (13.2-15.6) | 14.2 (13.4-15.3) | 0.1461 |
| Platelets (× 1000/μL) | 176 (108-223) | 198 (159-237) | < 0.0001 |
| Creatinine (mg/dL) | 0.8 (0.7-0.9) | 0.8 (0.7-0.9) | 0.9771 |
| INR | 1.04 (1.00-1.18) | 1.00 (1.00-1.10) | 0.0001 |
| HCV RNA (× 106 IU/mL) | 1.0 (0.3-2.5) | 0.9 (0.3-2.8) | 0.9636 |
- Citation: Janczura J, Brzdęk M, Flisiak R, Dobrowolska K, Brzdęk K, Rzymski P, Zarębska-Michaluk D. Steatotic liver disease in patients with chronic hepatitis C. World J Hepatol 2025; 17(12): 113639
- URL: https://www.wjgnet.com/1948-5182/full/v17/i12/113639.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i12.113639